Peroral endoscopic cardial constriction in gastroesophageal reflux disease

Effect and Safety of Peroral Endoscopic Cardial Constriction for Gastroesophageal Reflux Disease

Gastroesophageal reflux-induced bronchial constriction.

Endoscopic treatment of gastroesophageal reflux disease.

Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (GERD). Most of these therapies have been abandoned, because they were ineffective and/or had significant adverse effects. However, there are currently two therapies (Stretta, EsophyX) that have US Food and Drug Administration approval a...

Treatment of gastroesophageal reflux disease: endoscopic aspects.

Gastroesophageal reflux disease (GERD) is a very common chronic disorder manifesting itself as heartburn, regurgitation, or dysphagia, possibly leading to esophagitis, Barrett's esophagus and adenocarcinoma, and has a major impact on the patient's quality of life. Both medical treatment and surgery are well-established methods with several limitations. Recently, three types of endoscopic method...

Endoscopic therapy for gastroesophageal reflux disease.

Many new and developing endoscopic techniques for treatment of gastroesophageal reflux disease (GERD) are now or will soon be available for clinical use. These new therapies are directed to the gastroesophageal junction and include three basic techniques, which are outlined in this review: thermal remodeling and neurolysis of the lower esophageal sphincter (LES) zone; bulking or reinforcing of ...